Related Experiment Video
Updated: Aug 19, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
A population-based serological study of post-COVID syndrome prevalence and risk factors in children and adolescents
Roxane Dumont1, Viviane Richard1, Elsa Lorthe1
1Unit of Population Epidemiology, Division of Primary Care Medicine, Geneva University Hospitals, Geneva, Switzerland.
Insights
Pediatric post-COVID syndrome affects 9.1% of seropositive children, especially adolescents. Risk factors include older age, lower socioeconomic status, and chronic conditions like asthma, highlighting the need for early screening.
Area of Science:
- Pediatric infectious diseases
- Public health
- Epidemiology
Background:
- Post-COVID syndrome in children and adolescents is under-researched.
- Understanding its prevalence and risk factors is crucial for effective management.
Purpose of the Study:
- To investigate the prevalence and risk factors of pediatric post-COVID syndrome.
- To stratify findings based on serological status in a population-based sample.
Main Methods:
- Utilized data from the SEROCoV-KIDS cohort study in Geneva, Switzerland.
- Tested 1034 children (6 months-17 years) for anti-SARS-CoV-2 antibodies.
- Collected parent-reported data on persistent symptoms (over 12 weeks) compatible with post-COVID.
Main Results:
- Seropositivity rate was 55.1% (570/1034).
- Prevalence of persistent symptoms was 9.1% in seropositive children vs. 5.0% in seronegatives (adjusted prevalence difference: 4.1%).
- Adolescents showed a higher risk (8.3%), with older age, lower socioeconomic status, and chronic conditions (especially asthma) identified as risk factors.
Conclusions:
- A significant proportion of SARS-CoV-2-seropositive children, particularly adolescents, experience persistent post-COVID symptoms.
- Findings underscore the need for early screening and primary care management of pediatric post-COVID.
- Further research is warranted to fully understand and address pediatric post-COVID syndrome.
Abstract:
Post-COVID syndrome remains poorly studied in children and adolescents. Here, we aimed to investigate the prevalence and risk factors of pediatric post-COVID in a population-based sample, stratifying by serological status. Children from the SEROCoV-KIDS cohort study (State of Geneva, Switzerland), aged 6 months to 17 years, were tested for anti-SARS-CoV-2 N antibodies (December 2021-February 2022) and parents filled in a questionnaire on persistent symptoms in their children (lasting over 12 weeks) compatible with post-COVID. Of 1034 children tested, 570 (55.1%) were seropositive. The sex- and age-adjusted prevalence of persistent symptoms among seropositive children was 9.1% (95%CI: 6.7;11.8) and 5.0% (95%CI: 3.0;7.1) among seronegatives, with an adjusted prevalence difference (ΔaPrev) of 4.1% (95%CI: 1.1;7.3). Stratifying per age group, only adolescents displayed a substantial risk of having post-COVID symptoms (ΔaPrev = 8.3%, 95%CI: 3.5;13.5). Identified risk factors for post-COVID syndrome were older age, having a lower socioeconomic status and suffering from chronic health conditions, especially asthma. Our findings show that a significant proportion of seropositive children, particularly adolescents, experienced persistent COVID symptoms. While there is a need for further investigations, growing evidence of pediatric post-COVID urges early screening and primary care management.
Related Concept Videos
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Bias in Epidemiological Studies
Bullying

